Clinical decision support (CDS) tools are electronic systems that take information in patients' electronic health records and make suggestions to clinicians about how to care for patients. These tools can, for example, see ...
Jun 9, 2022
0
5
For persons aged 60 years or older with displaced distal radius fracture, surgical treatment seems not to be better than nonsurgical treatment for patient-reported wrist function, according to a study published online April ...
Apr 27, 2022
0
3
Placing hospitalized COVID-19 patients on their stomach is helpful if they're on a mechanical ventilator, but a new study suggests it's not a good idea for patients who are not intubated.
Apr 19, 2022
0
10
Best known therapeutically as a treatment for bipolar disorder, lithium has long intrigued researchers with its potential age-defying properties.
Apr 11, 2022
0
18
Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, ...
Apr 4, 2022
0
4
More than 40% of hospitalized individuals with COVID-19 have diabetes. But why is having diabetes a major risk factor for a more serious COVID-19 illness? Researchers now are starting to put the puzzle together.
Apr 4, 2022
0
4
Additional doses of COVID-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, say experts in The BMJ today.
Mar 2, 2022
0
10
(HealthDay)—The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease (IBD), according to a review published in the December issue of Gastroenterology.
Nov 24, 2021
0
1
Colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn't lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients, finds a pooled analysis of the available evidence, ...
Nov 22, 2021
0
7
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab—two monoclonal antibody treatments under Food and Drug Administration emergency use authorization—keep high-risk ...
Aug 30, 2021
0
76
